Literature DB >> 2155263

Induction of macrophage Ia expression in vivo by a synthetic block copolymer, L81.

D A Howerton1, R L Hunter, H K Ziegler, I J Check.   

Abstract

Certain synthetic, nonionic, block copolymers of polyoxypropylene and polyoxyethylene are potent immunoadjuvants. While investigating their mechanisms of action, we found that one of these copolymers, L81, induced the expression of macrophage Ia in vivo. L81 is a 2750-Da, linear copolymer with a 43-unit core of hydrophobic polyoxypropylene flanked on each side by 3 U of hydrophilic polyoxyethylene. It induced threefold to sevenfold increases in the proportion of peritoneal macrophages expressing I-A from 5 to 7 days after an i.p. injection of 5 mg. As little as 1 mg caused a twofold increase. I-A density increased with time after injection of L81. Macrophages induced by L81 actively synthesized I-A, showing an 18-fold increase in biosynthetic capacity. Ia induction did not require the presence of mature T lymphocytes, because similar increases in I-A expression were seen in athymic and euthymic mice. L81-induced macrophages were 10-fold more effective than normal macrophages in presenting Ag to a T cell hybridoma. Other functional studies showed that they were primed for the secretion of superoxide ion and could be stimulated in vitro by IFN-gamma and LPS to lyse tumor target cells. These results suggest that the induction of macrophage Ia expression by L81 may play a role in its activity as an immunoadjuvant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155263

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Polymer genomics: an insight into pharmacology and toxicology of nanomedicines.

Authors:  Alexander V Kabanov
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

2.  Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.

Authors:  R Audran; Y Men; P Johansen; B Gander; G Corradin
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

3.  Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo.

Authors:  C Jagannath; H S Allaudeen; R L Hunter
Journal:  Antimicrob Agents Chemother       Date:  1995-06       Impact factor: 5.191

4.  Nonionic block copolymers potentiate activities of drugs for treatment of infections with Toxoplasma gondii.

Authors:  F G Araujo; T Slifer
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

Review 5.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.